Poly, I heard the company was in Sydney talking to a broking firm....I think Shaws....who were impressed by the companies potential as they saw the synergies between Resmed and KSX. Obviously Paul Eisen got their attention as well as the fact that health care insurers are on board endorsing the product to clients.....the word is further major insurers are negotiating with the company for their endorsement of the Personal Wheezeometer.
It's all good for the company and Eisen is no slouch.....I spoke to the large shareholder out of Sydney and he is saying the company is now ready for the world stage with Paul Eisen on board.
Hope he's right, I'm here for a takeout in the next 12 months at far higher levels than what we see now......good opportunity for new investors or a major house broker to get some significant upside on their investment.
Good luck to all holders.
DYOR.
KSX Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held